These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 644137)

  • 1. Irradiation therapy with 131I-6beta-iodocholesterol of metapyralone induced adrenal hyperplasia in rats.
    Tragl KH; Kinast H; Hinterberger H; Angelberger P; Kletter K
    Res Exp Med (Berl); 1978 Mar; 172(2):137-41. PubMed ID: 644137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of large doses of 131I-19-iodocholesterol on metapyralone-induced adrenal cortical hyperplasia in dogs.
    Anderson BG; Beierwaltes WH; Nishiyama RH; Ice RD
    J Nucl Med; 1975 Oct; 16(10):928-32. PubMed ID: 170381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Improved scintigraphic imaging of the adrenals with 6beta-131I-iodomethyl-cholesterol (author's transl)].
    Tragl KH; Angelberger P; Pils P; Wiesinger F; Kletter K
    Rofo; 1977 Oct; 127(4):365-9. PubMed ID: 144660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenal scanning and uptake with 131I-6beta-iodomethyl-nor-cholesterol.
    Ryo UY; Johnston AS; Kim I; Pinsky SM
    Radiology; 1978 Jul; 128(1):157-61. PubMed ID: 663202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenal Size and function after irradiation with 131I-6 beta-Iodocholesterol in rabbits.
    Tragl KH; Kinast H; Angelberger P; Hruby H; Steininger H; Kletter K; Dragosics B
    Res Exp Med (Berl); 1981; 179(3):215-21. PubMed ID: 6275474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 131I-iodocholesterol (NP-59) scintigraphy in adrenocortical diseases.
    Taillefer R; Soucy JP; Eybalin MC; Levasseur A
    J Can Assoc Radiol; 1983 Jun; 34(2):120-4. PubMed ID: 6885882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new and superior adrenal scanning agent, NP-59.
    Sarkar SD; Beierwaltes H; Ice RD; Basmadjian GP; Hetzel KR; Kennedy WP; Mason MM
    J Nucl Med; 1975 Nov; 16(11):1038-42. PubMed ID: 1185265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 19-lodocholesterol and 6-lodomethylnorcholesterol as adrenal-scanning agents.
    Couch MW; Williams CM
    J Nucl Med; 1977 Jul; 18(7):724-7. PubMed ID: 874152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroidal accumulation of 131I during adrenal gland scintigraphy with 131I-19-iodocholesterol: effects of thyroid blocking agents.
    Barbarino A; Troncone L; Salvo D; Pasargiklian E
    J Clin Endocrinol Metab; 1975 Aug; 41(2):405-7. PubMed ID: 51030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High thyroid radiation dose associated with 131-I-19-iodocholesterol adrenal scanning.
    O'Connor MK; Cullen MJ; Malone JF
    Br J Radiol; 1979 Feb; 52(614):130-3. PubMed ID: 427363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of 19-iodocholesterol-131I with 6beta-iodomethyl-19-norcholest-5(10)-en-3beta-ol-131I as an adrenal-scanning agent.
    Nitta K; Ogawa H; Ito T; Kojima M; Maeda M
    Chem Pharm Bull (Tokyo); 1976 Oct; 24(10):2322-6. PubMed ID: 1017078
    [No Abstract]   [Full Text] [Related]  

  • 12. 131I-19-iodocholesterol scanning of the adrenal: A new tool for the clinician.
    Skaggs RA; Winternitz WW
    J Ky Med Assoc; 1976 Jun; 74(6):290-1. PubMed ID: 932541
    [No Abstract]   [Full Text] [Related]  

  • 13. Adrenal imaging with 131I-19-iodocholesterol in the diagnostic evaluation of patients with aldosteronism.
    Seabold JE; Cohen EL; Beierwaltes WH; Hinerman DL; Nishiyama RH; Bookstein JJ; Ice RD; Balachandran S
    J Clin Endocrinol Metab; 1976 Jan; 42(1):41-51. PubMed ID: 1249193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative study of adrenal gland scanning agents, 6beta-iodomethyl-19-nor-cholest-5(10)-en-3beta-o1-131I (NCL-6-131I) and 131I-19-cholesterol (CL-19-131I)].
    Fukuchi S; Nakajima K; Miura T; Haruyama K; Kida T
    Kaku Igaku; 1976 Dec; 13(6):775-9. PubMed ID: 1035359
    [No Abstract]   [Full Text] [Related]  

  • 15. 3-Ethyl and 3-methyl ethers of 19-iodocholesterol as potential adrenal scanning agents.
    Owoyale JA; Szinai SS
    Steroids; 1981 Feb; 37(2):133-41. PubMed ID: 7013159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of pharmacological preparations for the purpose of improving the visualization of the adrenals with 19-iodocholesterol-131I].
    Slavnov VN; Valueva GV; Markov VV; Luchitskiĭ EV; Iakovlev AA
    Med Radiol (Mosk); 1979 Jan; 24(1):37-41. PubMed ID: 215865
    [No Abstract]   [Full Text] [Related]  

  • 17. New adrenal-scanning agent.
    Kojima M; Maeda M; Ogawa H; Nitta K; Ito T
    J Nucl Med; 1975 Jul; 16(7):666-8. PubMed ID: 1151488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new and superior adrenal imaging agent, 131I-6beta-iodomethyl-19-nor-cholesterol (NP-59): evaluation in humans.
    Sarkar SD; Cohen EL; Beierwaltes WH; Ice RD; Cooper R; Gold EN
    J Clin Endocrinol Metab; 1977 Aug; 45(2):353-62. PubMed ID: 885997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake of 131I-19-cholesterol by normal and spontaneously hyperfunctioning canine adrenals.
    van den Brom WE; Rijnberk A; Lubberink AA; de Bruijne JJ
    Eur J Nucl Med; 1979 Feb; 4(1):61-67. PubMed ID: 227690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnosis of Cushing's syndrome using 131I-19-iodocholesterol uptake and adrenal imaging.
    Ortega D; Foz M; Doménech-Torné FM; Tresánchez JM
    Clin Endocrinol (Oxf); 1980 Aug; 13(2):145-9. PubMed ID: 7438469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.